# EDGAR Filing Document

**Accession Number:** 0001848416
**File Stem:** 0001493152-23-001819
**Filing Date:** 2023-1
**Character Count:** 11344
**Document Hash:** 30bf50ea05d6445d03a720a1127053b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-001819.hdr.sgml**: 20230119

**ACCESSION NUMBER**: 0001493152-23-001819

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230119

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230119

**DATE AS OF CHANGE**: 20230119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Verano Holdings Corp.
- **CENTRAL INDEX KEY:** 0001848416
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE PRODUCTION - CROPS [0100]
- **IRS NUMBER:** 981583243
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56342
- **FILM NUMBER:** 23535929

**BUSINESS ADDRESS:**
- **STREET 1:** 415 NORTH DEARBORN STREET
- **STREET 2:** 4TH FLOOR
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60654
- **BUSINESS PHONE:** 312-265-0730

**MAIL ADDRESS:**
- **STREET 1:** 415 NORTH DEARBORN STREET
- **STREET 2:** 4TH FLOOR
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60654

?xml version="1.0" encoding="utf-8"?

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934** 

**Date of Report (Date of earliest event reported): January 19, 2023** 

**VERANO HOLDINGS CORP.**

**(Exact Name of Registrant as Specified in its Charter)** 

------

---

| | | |
|:---|:---|:---|
| **British Columbia** | **000-56342** | **98-1583243** |
| **(State or Other Jurisdiction <br> of Incorporation)** | **(Commission <br> File Number)** | **(IRS Employer <br> Identification No.)** |

---

---

| | |
|:---|:---|
| **415 North Dearborn Street** **, 4th Floor,** |  |
| **Chicago, Illinois** | **60654** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**(312) 265-0730** 

**(Registrant's Telephone Number, Including Area Code)**

**N/A**

**(Former Name or Former Address, if Changed Since Last Report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| **N/A** | **N/A** | **N/A** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

**Item 8.01** **Other Events.**

On January 19, 2023, Verano Holdings Corp. (the "Company") issued a press release announcing the grand opening of MÜV Navarre on Friday, January 20, 2023, bringing the Company's total dispensary count to 63 in Florida and 121 nationwide. A copy of such press release is filed as Exhibit 99.1 to this report.

The information furnished under this item 8.01, including Exhibit 99.1 incorporated by reference herein, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

<u>Exhibit No.</u> <u>Description</u> <br> 99.1 [Press Release issued on January 19, 2023](ex99-1.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | VERANO HOLDINGS CORP. | VERANO HOLDINGS CORP. |
| Date: January 19, 2023 | By: | */s/ Darren Weiss* |
|  | Name: | Darren Weiss |
|  | Title: | Chief Operating Officer, Chief Legal Officer, General Counsel & Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

![A black and white logo Description automatically generated with low confidence](ex99-1_001.jpg)

**Verano Announces the Opening of MÜV Navarre, the Company's 63<sup>rd</sup> Florida Location** 

● MÜV
 is the first medical cannabis dispensary in Navarre, a town with a population of nearly 40,000<sup>1</sup>

● MÜV
 Navarre is located at 6863 Navarre Parkway, a busy thoroughfare with an average daily traffic count of 37,500 vehicles<sup>2</sup>

● Verano's
 active operations span 13 states, comprised of 121 dispensaries and 14 cultivation and processing facilities with more than 1 million
 square feet of cultivation capacity

CHICAGO, January 19, 2023 – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced the opening of MÜV Navarre on Friday, January 20, the Company's 63<sup>rd</sup> Florida dispensary and 121<sup>st</sup> nationwide. MÜV Navarre, located at 6863 Navarre Parkway, is open Monday through Saturday from 9 a.m. to 5 p.m. and Sunday from 11 a.m. to 5 p.m., local time.

According to Florida's Office of Medical Marijuana Use, there are currently over 783,000 qualified medical cannabis patients in the state. Florida medical cannabis sales are projected to potentially reach $2.5 billion by 2026, as reported by <u>MJBiz Factbook 2022</u>.

"We're excited to welcome patients at MÜV Navarre, the city's first medical cannabis dispensary, where our dedicated team of cannabis advisors will provide guidance and care to patients throughout the Panhandle," said John Tipton, President of Verano. "Opening MÜV Navarre compliments our existing dispensaries in Pensacola and Shalimar, and we're thrilled to add another convenient location for Florida's medical cannabis patients and increase their access to medicine."

As a demonstration of Verano's commitment to provide a convenient and reliable experience for Florida patients, MÜV dispensaries feature online menus for effortless browsing of their extensive, award-winning product selection, including the Company's signature Verano Reserve and Sweet Supply flower, Encore edibles, and Savvy flower and extracts. The Company also offers one-on-one virtual and in-store consultations at no cost to the patient and provides patient-centric concierge services via phone, email, web chat and text to address patient questions and inquiries. For additional convenience and accessibility, patients can choose to order ahead at muvfl.com or through the MÜV mobile application available in the Google Play and Apple App stores for express in-store pickup.

MÜV's comprehensive product selection includes edibles, chocolates and lozenges, flower, pre-rolls, an array of vaporizer pens, concentrates, metered-dose inhalers, topicals and oral sprays; along with patented encapsulation formulations in its EnCaps™ capsules, tinctures, 72-hour transdermal patches and transdermal gels.

For more information about MÜV Navarre medical cannabis dispensary, visit <u>muvfl.com</u>.

<sup>1</sup> <u>United States Census Bureau</u>

<sup>2</sup> <u>Florida Department of Transportation</u>

**About Verano**

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano<sup>™</sup>, Avexia<sup>™,</sup> Encore<sup>™,</sup> and MÜV<sup>™</sup>. Verano's portfolio encompasses 14 U.S. states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf<sup>™</sup> and MÜV<sup>™</sup>, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at <u>www.verano.com</u>.

**Contacts:**

**Media**

Verano

Grace Bondy

Manager, Communications

<u>Grace.Bondy@verano.com</u>

**Investors**

Verano

Julianna Paterra, CFA

Director, Investor Relations

<u>Julianna.Paterra@verano.com</u>

**Forward Looking Statements**

This press release may contain "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "future", "scheduled", "estimates", "forecasts", "projects" "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company's registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###